Variables Influencing 6-Month Relapse in Early-Stage Hepatocellular Carcinoma After Radiofrequency Ablation

Objectives: Hepatocellular carcinoma (HCC) emerged as a global health concern in 2020, ranking as the sixth most diagnosed cancer and the third leading cause of cancer-related death. This study analyzed predictors of 6-month relapse in early-stage HCC patients after Radiofrequency Ablation (RFA). M...

Full description

Saved in:
Bibliographic Details
Main Authors: Yumchinserchin Narangerel, Gonchigsuren Dagvasumberel, Enebish Sundui, Adilsaikhan Mendjargal
Format: Article
Language:English
Published: Mongolian National University of Medical Sciences 2024-03-01
Series:Central Asian Journal of Medical Sciences
Subjects:
Online Access:https://www.mongoliajol.info/index.php/CAJMS/article/view/3574
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1849330037155692544
author Yumchinserchin Narangerel
Gonchigsuren Dagvasumberel
Enebish Sundui
Adilsaikhan Mendjargal
author_facet Yumchinserchin Narangerel
Gonchigsuren Dagvasumberel
Enebish Sundui
Adilsaikhan Mendjargal
author_sort Yumchinserchin Narangerel
collection DOAJ
description Objectives: Hepatocellular carcinoma (HCC) emerged as a global health concern in 2020, ranking as the sixth most diagnosed cancer and the third leading cause of cancer-related death. This study analyzed predictors of 6-month relapse in early-stage HCC patients after Radiofrequency Ablation (RFA). Methods: This retrospective study, from January 1, 2018, to December 31, 2022, meticulously explored ablation methods for early-stage HCC treatment. Data collection included a 6-month relapse definition, demographic details, and tumor-related variables. Results: Over five years, 483 participants underwent RFA for early-stage HCC, presenting diverse demographic and tumor-related profiles. Significant associations were found between relapse and factors such as gender, smoking, alcohol use, tumor size, specific tumor locations, and pre-treatment AST levels. Notably, 6.8% of participants experienced relapse within six months. In the multivariate analysis, adjusting for confounders, smoking (p = 0.014), tumor size > 3cm (p < 0.001), tumor location S2 (p < 0.001), and pre-treatment AST levels (p = 0.015) remained significant predictors. Conclusion: This study sheds light on the complex dynamics of 6-month relapse in early-stage HCC patients, emphasizing the significance of predictors such as smoking, tumor size, tumor location, and pre-treatment AST levels.
format Article
id doaj-art-fea652fe3ee64d9a9f370b4f4a457e77
institution Kabale University
issn 2413-8681
2414-9772
language English
publishDate 2024-03-01
publisher Mongolian National University of Medical Sciences
record_format Article
series Central Asian Journal of Medical Sciences
spelling doaj-art-fea652fe3ee64d9a9f370b4f4a457e772025-08-20T03:47:06ZengMongolian National University of Medical SciencesCentral Asian Journal of Medical Sciences2413-86812414-97722024-03-01101152510.24079/cajms.2024.01.0033525Variables Influencing 6-Month Relapse in Early-Stage Hepatocellular Carcinoma After Radiofrequency AblationYumchinserchin Narangerel0https://orcid.org/0009-0002-0007-9620Gonchigsuren Dagvasumberel1Enebish Sundui2Adilsaikhan Mendjargal3 Department of Interventional Radiology National Cancer Center of Mongolia, Ulaanbaatar, MongoliaDepartment of Oncology, Mongolian National University of Medical Sciences, Ulaanbaatar, MongoliaDepartment of Anatomy, Mongolian National University of Medical Sciences, Ulaanbaatar, MongoliaDepartment of Radiology, Mongolian National University of Medical Sciences, Ulaanbaatar, MongoliaObjectives: Hepatocellular carcinoma (HCC) emerged as a global health concern in 2020, ranking as the sixth most diagnosed cancer and the third leading cause of cancer-related death. This study analyzed predictors of 6-month relapse in early-stage HCC patients after Radiofrequency Ablation (RFA). Methods: This retrospective study, from January 1, 2018, to December 31, 2022, meticulously explored ablation methods for early-stage HCC treatment. Data collection included a 6-month relapse definition, demographic details, and tumor-related variables. Results: Over five years, 483 participants underwent RFA for early-stage HCC, presenting diverse demographic and tumor-related profiles. Significant associations were found between relapse and factors such as gender, smoking, alcohol use, tumor size, specific tumor locations, and pre-treatment AST levels. Notably, 6.8% of participants experienced relapse within six months. In the multivariate analysis, adjusting for confounders, smoking (p = 0.014), tumor size > 3cm (p < 0.001), tumor location S2 (p < 0.001), and pre-treatment AST levels (p = 0.015) remained significant predictors. Conclusion: This study sheds light on the complex dynamics of 6-month relapse in early-stage HCC patients, emphasizing the significance of predictors such as smoking, tumor size, tumor location, and pre-treatment AST levels.https://www.mongoliajol.info/index.php/CAJMS/article/view/3574ablation safetyhepatic tumorsresidual tumorablation techniquesradiofrequency ablation
spellingShingle Yumchinserchin Narangerel
Gonchigsuren Dagvasumberel
Enebish Sundui
Adilsaikhan Mendjargal
Variables Influencing 6-Month Relapse in Early-Stage Hepatocellular Carcinoma After Radiofrequency Ablation
Central Asian Journal of Medical Sciences
ablation safety
hepatic tumors
residual tumor
ablation techniques
radiofrequency ablation
title Variables Influencing 6-Month Relapse in Early-Stage Hepatocellular Carcinoma After Radiofrequency Ablation
title_full Variables Influencing 6-Month Relapse in Early-Stage Hepatocellular Carcinoma After Radiofrequency Ablation
title_fullStr Variables Influencing 6-Month Relapse in Early-Stage Hepatocellular Carcinoma After Radiofrequency Ablation
title_full_unstemmed Variables Influencing 6-Month Relapse in Early-Stage Hepatocellular Carcinoma After Radiofrequency Ablation
title_short Variables Influencing 6-Month Relapse in Early-Stage Hepatocellular Carcinoma After Radiofrequency Ablation
title_sort variables influencing 6 month relapse in early stage hepatocellular carcinoma after radiofrequency ablation
topic ablation safety
hepatic tumors
residual tumor
ablation techniques
radiofrequency ablation
url https://www.mongoliajol.info/index.php/CAJMS/article/view/3574
work_keys_str_mv AT yumchinserchinnarangerel variablesinfluencing6monthrelapseinearlystagehepatocellularcarcinomaafterradiofrequencyablation
AT gonchigsurendagvasumberel variablesinfluencing6monthrelapseinearlystagehepatocellularcarcinomaafterradiofrequencyablation
AT enebishsundui variablesinfluencing6monthrelapseinearlystagehepatocellularcarcinomaafterradiofrequencyablation
AT adilsaikhanmendjargal variablesinfluencing6monthrelapseinearlystagehepatocellularcarcinomaafterradiofrequencyablation